Background: High blood pressure (BP) continues to be a major, poorly controlled but
modifiable risk factor for cardiovascular death. Among key Western lifestyle factors, a diet …

There is increasing evidence of the influence of the gut microbiota on hypertension and its
complications, such as chronic kidney disease, stroke, heart failure, and myocardial …

Background: Dietary intake of fruit and vegetables is associated with lower incidence of
hypertension, but the mechanisms involved have not been elucidated. Here, we evaluated …

Abstract Purpose of Review To discuss the interplay behind how a high-fibre diet leads to
lower blood pressure (BP) via the gut microbiome. Recent Findings Compelling evidence …

Abstract Purpose of this Review This review assesses the latest evidence linking short-chain
fatty acids (SCFA) with host metabolic health and cardiovascular disease (CVD) risk and …

Objective To investigate the beneficial role of prebiotics on endothelial dysfunction, an early
key marker of cardiovascular diseases, in an original mouse model linking steatosis and …

Recent evidence supports a role for the gut microbiota in hypertension, but whether
ambulatory blood pressure is associated with gut microbiota and their metabolites remains …

Abstract Purpose of Review The purpose of this review is to summarize the evidence
supporting a role of short-chain fatty acids (SCFAs) as messengers facilitating cross talk …

Gut microbiota play a significant role in host metabolic processes, and recent metagenomic
surveys have revealed that they are involved in host immune modulation and influence host …

Short chain fatty acid (SCFA) metabolites are byproducts of gut microbial metabolism that
are known to affect host physiology via host G protein-coupled receptor (GPCRs). We …